• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hillrom secures EUA for use of MetaNeb system with coronavirus patients

Hillrom secures EUA for use of MetaNeb system with coronavirus patients

April 21, 2020 By Sean Whooley

HillromHillrom (NYSE:HRC) announced today that it received FDA emergency use authorization (EUA) for its MetaNeb system to help COVID-19 patients.

Chicago-based Hillrom designed MetaNeb to combine lung expansion, secretion clearance and aerosol delivery into a single therapy session available for use with any ventilator. MetaNeb includes a closed-circuit design with a bacterial-viral filter to protect patients from aerosolized particles that might escape during treatment, according to a news release.

“Our team has been working tirelessly to rapidly develop and deliver critical care devices and solutions for COVID -19 patients, from triage to treatment for those in the ICU,” Hillrom president & CEO John Groetelaars said in the release. “In addition to receiving emergency use authorization to enhance our MetaNeb system, we are also pleased to offer new mobile care communications and innovative vital signs remote monitoring solutions to help save lives.”

Hillrom’s additional offerings in the coronavirus crisis include integrated digital respiratory rate capture capabilities in its Welch Allyn Connex spot monitor, allowing care teams to accurately monitor the respiratory rate of COVID-19 patients with the potential for earlier detection and intervention.

The company’s Spot 4400 vital signs monitor is set to receive a remote monitoring platform as well so clinicians can remotely receive a complete set of vitals through a smartphone app and a web portal. The company also created a cloud-hosted version of its Voalte mobile solution for allowing caregivers and patients in field hospitals to communicate.

Hillrom also announced that it is partnering with AgileMD to offer constantly updated COVID-19 clinical pathways from leading centers managing coronavirus patients. The partnership sets out to offer access to advanced COVID-19 pathways and analytics to give providers a way to implement best practices for evidence-based care.

“Hillrom’s delivery of these innovative solutions and clinical protocols demonstrates the breadth of our portfolio, our ability to meet the rapidly evolving needs of patients, and the ingenuity and dedication of our employees globally,” Groetelaars said. “Our teams are demonstrating their unwavering commitment and focus on our mission of enhancing outcomes for patients and caregivers as the fight against COVID-19 continues.”

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Respiratory Tagged With: coronavirus, COVID-19, Hillrom

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy